1
|
Putri AD, Hsu MJ, Han CL, Chao FC, Hsu CH, Lorenz CD, Hsieh CM. Differential cellular responses to FDA-approved nanomedicines: an exploration of albumin-based nanocarriers and liposomes in protein corona formation. Nanoscale 2023; 15:17825-17838. [PMID: 37850423 DOI: 10.1039/d3nr04862d] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/19/2023]
Abstract
Albumin nanoparticles (NPs) and PEGylated liposomes have garnered tremendous interest as therapeutic drug carriers due to their unique physicochemical properties. These unique properties also have significant effects on the composition and structure of the protein corona formed around these NPs in a biological environment. Herein, protein corona formation on albumin NPs and liposomes was simultaneously evaluated through in vitro and simulation studies. The sizes of both types of NPs increased with more negatively charged interfaces upon being introduced into fetal bovine serum. Gel electrophoresis and label-free quantitative proteomics were performed to identify proteins recruited to the hard corona, and fewer proteins were found in albumin NPs than in liposomes, which is in accordance with isothermal titration calorimetry. The cellular uptake efficiency of the two NPs significantly differed in different serum concentrations, which was further scrutinized by loading an anticancer compound into albumin NPs. The presence of the hard protein corona increased the cellular uptake of albumin NPs in comparison with liposomes. In our simulation study, a specific receptor present in the membrane was greatly attracted to the albumin-apolipoprotein E complex. Overall, this study not only evaluated protein corona formation on albumin NPs, but also made promising advancements toward albumin- and liposome-based therapeutic systems.
Collapse
Affiliation(s)
- Athika Darumas Putri
- School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, 11031, Taiwan.
- Semarang College of Pharmaceutical Sciences (STIFAR), Semarang City, 50192, Indonesia
| | - Ming-Jen Hsu
- Department of Pharmacology, Taipei Medical University, Taipei, 11031, Taiwan
| | - Chia-Li Han
- Master Program in Clinical Genomics and Proteomics, College of Pharmacy, Taipei Medical University, Taipei, 11031, Taiwan
| | - Fang-Ching Chao
- Université Paris-Saclay, CNRS UMR 8612, Institut Galien Paris-Saclay, Châtenay-Malabry, France
| | - Chun-Hua Hsu
- Department of Agricultural Chemistry, National Taiwan University, Taipei, 10617, Taiwan
| | - Christian D Lorenz
- Biological Physics and Soft Matter Group, Department of Physics, King's College London, London WC2R 2LS, UK
| | - Chien-Ming Hsieh
- School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, 11031, Taiwan.
- Ph.D. Program in Drug Discovery and Development Industry, College of Pharmacy, Taipei Medical University, Taipei, 11031, Taiwan
| |
Collapse
|
2
|
Ayu Eka Pitaloka D, Izzati A, Rafa Amirah S, Abdan Syakuran L, Muhammad Irham L, Darumas Putri A, Adikusuma W. Bioinformatics Analysis to Uncover the Potential Drug Targets Responsible for Mycobacterium tuberculosis Peptidoglycan and Lysine Biosynthesis. Bioinform Biol Insights 2023; 17:11779322231171774. [PMID: 37187890 PMCID: PMC10176782 DOI: 10.1177/11779322231171774] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/29/2022] [Accepted: 04/07/2023] [Indexed: 05/17/2023] Open
Abstract
Drug-resistant tuberculosis (TB), which results mainly from the selection of naturally resistant strains of Mycobacterium tuberculosis (MTB) due to mismanaged treatment, poses a severe challenge to the global control of TB. Therefore, screening novel and unique drug targets against this pathogen is urgently needed. The metabolic pathways of Homo sapiens and MTB were compared using the Kyoto Encyclopedia of Genes and Genomes tool, and further, the proteins that are involved in the metabolic pathways of MTB were subtracted and proceeded to protein-protein interaction network analysis, subcellular localization, drug ability testing, and gene ontology. The study aims to identify enzymes for the unique pathways for further screening to determine the feasibility of the therapeutic targets. The qualitative characteristics of 28 proteins identified as drug target candidates were studied. The results showed that 12 were cytoplasmic, 2 were extracellular, 12 were transmembrane, and 3 were unknown. Furthermore, druggability analysis revealed 14 druggable proteins, of which 12 were novel and responsible for MTB peptidoglycan and lysine biosynthesis. The novel targets obtained in this study are used to develop antimicrobial treatments against pathogenic bacteria. Future studies should further shed light on the clinical implementation to identify antimicrobial therapies against MTB.
Collapse
Affiliation(s)
- Dian Ayu Eka Pitaloka
- Department of Pharmacology and Clinical
Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, Indonesia
- Center for Translational Biomarker
Research, Universitas Padjadjaran, Sumedang, Indonesia
| | - Afifah Izzati
- Department of Pharmacology and Clinical
Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, Indonesia
| | - Siti Rafa Amirah
- Department of Pharmacology and Clinical
Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, Indonesia
| | - Luqman Abdan Syakuran
- Genetics and Molecular Laboratory,
Faculty of Biology, Jenderal Soedirman University, Purwokerto, Indonesia
| | - Lalu Muhammad Irham
- Faculty of Pharmacy, Universitas Ahmad
Dahlan, Yogyakarta, Indonesia
- Research Center for Pharmaceutical
Ingrediensts and Traditional Medicine, National Research and Inovation Agency
(BRIN), South Tangerang, Indonesia
| | | | - Wirawan Adikusuma
- Department of Pharmacy, Faculty of
Health Science, Universitas Muhammadiyah Mataram, Mataram, Indonesia
- Research Center for Vaccine and Drugs,
National Research and Inovation Agency (BRIN), South Tangerang, Indonesia
| |
Collapse
|
3
|
Hsieh CM, Yang TL, Putri AD, Chen CT. Application of Design of Experiments in the Development of Self-Microemulsifying Drug Delivery Systems. Pharmaceuticals (Basel) 2023; 16:283. [PMID: 37259427 PMCID: PMC9958669 DOI: 10.3390/ph16020283] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/29/2022] [Revised: 02/10/2023] [Accepted: 02/10/2023] [Indexed: 08/27/2023] Open
Abstract
Oral delivery has become the route of choice among all other types of drug administrations. However, typical chronic disease drugs are often poorly water-soluble, have low dissolution rates, and undergo first-pass metabolism, ultimately leading to low bioavailability and lack of efficacy. The lipid-based formulation offers tremendous benefits of using versatile excipients and has great compatibility with all types of dosage forms. Self-microemulsifying drug delivery system (SMEDDS) promotes drug self-emulsification in a combination of oil, surfactant, and co-surfactant, thereby facilitating better drug solubility and absorption. The feasible preparation of SMEDDS creates a promising strategy to improve the drawbacks of lipophilic drugs administered orally. Selecting a decent mixing among these components is, therefore, of importance for successful SMEDDS. Quality by Design (QbD) brings a systematic approach to drug development, and it offers promise to significantly improve the manufacturing quality performance of SMEDDS. Furthermore, it could be benefited efficiently by conducting pre-formulation studies integrated with the statistical design of experiment (DoE). In this review, we highlight the recent findings for the development of microemulsions and SMEDDS by using DoE methods to optimize the formulations for drugs in different excipients with controllable ratios. A brief overview of DoE concepts is discussed, along with its technical benefits in improving SMEDDS formulations.
Collapse
Affiliation(s)
- Chien-Ming Hsieh
- School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei 110, Taiwan
- Ph.D. Program in Drug Discovery and Development Industry, College of Pharmacy, Taipei Medical University, Taipei 110, Taiwan
| | - Ting-Lun Yang
- Department of Biochemical Science and Technology, National Taiwan University, Taipei 106, Taiwan
| | - Athika Darumas Putri
- School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei 110, Taiwan
- Department of Pharmaceutical Chemistry, Semarang College of Pharmaceutical Sciences (STIFAR), Semarang City 50192, Indonesia
| | - Chin-Tin Chen
- Department of Biochemical Science and Technology, National Taiwan University, Taipei 106, Taiwan
| |
Collapse
|
4
|
Murti BT, Putri AD, Huang YJ, Wei SM, Peng CW, Yang PK. Clinically oriented Alzheimer's biosensors: expanding the horizons towards point-of-care diagnostics and beyond. RSC Adv 2021; 11:20403-20422. [PMID: 35479927 PMCID: PMC9033966 DOI: 10.1039/d1ra01553b] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/26/2021] [Accepted: 05/28/2021] [Indexed: 12/30/2022] Open
Abstract
The development of minimally invasive and easy-to-use sensor devices is of current interest for ultrasensitive detection and signal recognition of Alzheimer's disease (AD) biomarkers. Over the years, tremendous effort has been made on diagnostic platforms specifically targeting neurological markers for AD in order to replace the conventional, laborious, and invasive sampling-based approaches. However, the sophistication of analytical outcomes, marker inaccessibility, and material validity strongly limit the current strategies towards effectively predicting AD. Recently, with the promising progress in biosensor technology, the realization of a clinically applicable sensing platform has become a potential option to enable early diagnosis of AD and other neurodegenerative diseases. In this review, various types of biosensors, which include electrochemical, fluorescent, plasmonic, photoelectrochemical, and field-effect transistor (FET)-based sensor configurations, with better clinical applicability and analytical performance towards AD are highlighted. Moreover, the feasibility of these sensors to achieve point-of-care (POC) diagnosis is also discussed. Furthermore, by grafting nanoscale materials into biosensor architecture, the remarkable enhancement in durability, functionality, and analytical outcome of sensor devices is presented. Finally, future perspectives on further translational and commercialization pathways of clinically driven biosensor devices for AD are discussed and summarized.
Collapse
Affiliation(s)
- Bayu Tri Murti
- Graduate Institute of Biomedical Materials and Tissue Engineering, College of Biomedical Engineering, Taipei Medical University Taipei Taiwan
- Semarang College of Pharmaceutical Sciences (STIFAR) Semarang City Indonesia
| | - Athika Darumas Putri
- Semarang College of Pharmaceutical Sciences (STIFAR) Semarang City Indonesia
- Department of Pharmaceutical Sciences, School of Pharmacy, College of Pharmacy, Taipei Medical University Taipei Taiwan
| | - Yi-June Huang
- Graduate Institute of Nanomedicine and Medical Engineering, College of Biomedical Engineering, Taipei Medical University Taipei Taiwan
- International Ph.D. Program in Biomedical Engineering, College of Biomedical Engineering, Taipei Medical University Taipei Taiwan
| | - Shih-Min Wei
- Graduate Institute of Nanomedicine and Medical Engineering, College of Biomedical Engineering, Taipei Medical University Taipei Taiwan
- International Ph.D. Program in Biomedical Engineering, College of Biomedical Engineering, Taipei Medical University Taipei Taiwan
| | - Chih-Wei Peng
- International Ph.D. Program in Biomedical Engineering, College of Biomedical Engineering, Taipei Medical University Taipei Taiwan
- School of Biomedical Engineering, College of Biomedical Engineering, Taipei Medical University Taipei Taiwan
| | - Po-Kang Yang
- Graduate Institute of Nanomedicine and Medical Engineering, College of Biomedical Engineering, Taipei Medical University Taipei Taiwan
- International Ph.D. Program in Biomedical Engineering, College of Biomedical Engineering, Taipei Medical University Taipei Taiwan
- Department of Biomedical Sciences and Engineering, National Central University Chung-li Taiwan
| |
Collapse
|
5
|
Gupta S, Jain U, Murti BT, Putri AD, Tiwari A, Chauhan N. Nanohybrid-based immunosensor prepared for Helicobacter pylori BabA antigen detection through immobilized antibody assembly with @ Pd nano/rGO/PEDOT sensing platform. Sci Rep 2020; 10:21217. [PMID: 33277599 PMCID: PMC7719176 DOI: 10.1038/s41598-020-78068-w] [Citation(s) in RCA: 18] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/23/2019] [Accepted: 10/19/2020] [Indexed: 12/31/2022] Open
Abstract
The gastric colonization of human hosts by Helicobacter pylori (H. pylori) increases the risk of developing gastritis, ulcers and gastric cancer. To detect H. pylori, a nanohybrid-based BabA immunosensor is developed herein. BabA is an outer membrane protein and one of the major virulence factors of H. pylori. To design the immunosensor, an Au electrode is loaded with palladium nanoparticles (Pdnano) by electrodeposition to generate reduced graphene oxide (rGO)/poly(3,4-ethylenedioxythiophene) (PEDOT). The immobilization of these nanostructured materials imparts a large surface area and electroconductivity to bio-immune-sensing molecules (here, the BabA antigen and antibodies). After optimization, the fabricated immunosensor has the ability to detect antigens (H. pylori) in a linear range from 0.2 to 20 ng/mL with a low LOD (0.2 ng/mL). The developed immunosensor is highly specific, sensitive and reproducible. Additionally, in silico methods were employed to better understand the hybrid nanomaterials of the fabricated Pdnano/rGO/PEDOT/Au electrode. Simulations performed by molecular docking, and Metropolis Monte Carlo adsorption studies were conducted. The results revealed that the hybrid nanomaterials exhibit a stable antigen-antibody complex of BabA, yielding the lowest binding energy in relation to the electrode materials, emphasizing the functionality of the constructed electrodes in the electrochemical immunosensor.
Collapse
Affiliation(s)
- Shaivya Gupta
- Amity Institute of Nanotechnology, Amity University, Noida, Uttar Pradesh, 201303, India
| | - Utkarsh Jain
- Amity Institute of Nanotechnology, Amity University, Noida, Uttar Pradesh, 201303, India
| | - Bayu Tri Murti
- Department of Chemistry, Durban University of Technology, Durban, 4000, South Africa
- Semarang College of Pharmaceutical Sciences, Jl. Letnand Jendral Sarwo Edi Wibowo, Semarang City, 50192, Indonesia
| | - Athika Darumas Putri
- Department of Chemistry, Durban University of Technology, Durban, 4000, South Africa
- Semarang College of Pharmaceutical Sciences, Jl. Letnand Jendral Sarwo Edi Wibowo, Semarang City, 50192, Indonesia
| | - Ashutosh Tiwari
- Institute of Advanced Materials, IAAM, Gammalkilsvägen 18, 590 53, Ulrika, Sweden
- VBRI, 7/16 Kalkaji Extn., New Delhi, 110 019, India
| | - Nidhi Chauhan
- Amity Institute of Nanotechnology, Amity University, Noida, Uttar Pradesh, 201303, India.
| |
Collapse
|
6
|
Putri AD, Murti BT, Kanchi S, Sabela MI, Bisetty K, Tiwari A, Inamuddin, Asiri AM. Computational studies on the molecular insights of aptamer induced poly(N-isopropylacrylamide)-graft-graphene oxide for on/off- switchable whole-cell cancer diagnostics. Sci Rep 2019; 9:7873. [PMID: 31133671 PMCID: PMC6536548 DOI: 10.1038/s41598-019-44378-x] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/26/2018] [Accepted: 05/13/2019] [Indexed: 01/04/2023] Open
Abstract
This work deals with first-principles and in silico studies of graphene oxide-based whole-cell selective aptamers for cancer diagnostics utilising a tunable-surface strategy. Herein, graphene oxide (GO) was constructed as a surface-based model with poly(N-isopropylacrylamide) (PNIPAM) covalently grafted as an "on/off"-switch in triggering interactions with the cancer-cell protein around its lower critical solution temperature. The atomic building blocks of the aptamer and the PNIPAM adsorbed onto the GO was investigated at the density functional theory (DFT) level. The presence of the monomer of PNIPAM stabilised the system's π-π interaction between GO and its nucleobases as confirmed by higher bandgap energy, satisfying the eigenvalues of the single-point energy observed rather than the nucleobase and the GO complex independently. The unaltered geometrical structures of the surface emphasise the physisorption type interaction between the nucleobase and the GO/NIPAM surface. The docking result for the aptamer and the protein, highlighted the behavior of the PNIPAM-graft-GO is exhibiting globular and extended conformations, further supported by molecular dynamics (MD) simulations. These studies enabled a better understanding of the thermal responsive behavior of the polymer-enhanced GO complex for whole-cell protein interactions through computational methods.
Collapse
Affiliation(s)
- Athika Darumas Putri
- Department of Chemistry, Faculty of Applied Science, Durban University of Technology, Durban, 4000, South Africa
- Semarang College of Pharmaceutical Sciences, Jl. Letnand Jendral Sarwo Edi Wibowo, Semarang City, 50192, Indonesia
| | - Bayu Tri Murti
- Department of Chemistry, Faculty of Applied Science, Durban University of Technology, Durban, 4000, South Africa
- Semarang College of Pharmaceutical Sciences, Jl. Letnand Jendral Sarwo Edi Wibowo, Semarang City, 50192, Indonesia
| | - Suvardhan Kanchi
- Department of Chemistry, Faculty of Applied Science, Durban University of Technology, Durban, 4000, South Africa
| | - Myalowenkosi I Sabela
- Department of Chemistry, Faculty of Applied Science, Durban University of Technology, Durban, 4000, South Africa
| | - Krishna Bisetty
- Department of Chemistry, Faculty of Applied Science, Durban University of Technology, Durban, 4000, South Africa.
| | - Ashutosh Tiwari
- Institute of Advanced Materials, UCS, Teknikringen 4A, Mjärdevi Science Park, SE-58330, Linköping, Sweden
- Vinoba Bhave Research Institute, Binda-Dhokri Road, Saidabad, Allahabad, 221508, India
| | - Inamuddin
- Chemistry Department, Faculty of Science, King Abdulaziz University, Jeddah, 21589, Saudi Arabia.
- Centre of Excellence for Advanced Materials Research, King Abdulaziz University, Jeddah, 21589, Saudi Arabia.
| | - Abdullah M Asiri
- Chemistry Department, Faculty of Science, King Abdulaziz University, Jeddah, 21589, Saudi Arabia
- Centre of Excellence for Advanced Materials Research, King Abdulaziz University, Jeddah, 21589, Saudi Arabia
| |
Collapse
|